PHRRF (PharmaTher Holdings) EPS (Basic): $-0.01 (TTM As of Feb. 2026)


What is PharmaTher Holdings EPS (Basic)?

PharmaTher Holdings PHRRF +4.74% EPS (Basic) is $-0.01 as of Feb. 2026. The stock has 2 warning signs investors should review.

PharmaTher Holdings's basic earnings per share (Basic EPS) for the three months ended in Feb. 2026 was $0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Feb. 2026 was $-0.01.

PharmaTher Holdings's EPS (Diluted) for the three months ended in Feb. 2026 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 was $-0.01.

PharmaTher Holdings's EPS without NRI for the three months ended in Feb. 2026 was $0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Feb. 2026 was -0.01.

During the past 3 years, the average EPS without NRI Growth Rate was 25.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, PharmaTher Holdings's highest 3-Year average EPS without NRI Growth Rate was 25.30% per year. The lowest was -5.90% per year. And the median was 9.70% per year.

PharmaTher Holdings  (OTCPK:PHRRF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

PharmaTher Holdings EPS (Basic) Related Terms

PharmaTher Holdings EPS (Basic) Historical Data

* Premium members only.

The historical data trend for PharmaTher Holdings's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaTher Holdings EPS (Basic) Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23 May24 May25
EPS (Basic)
0.03 -0.04 -0.05 -0.03 -0.01

PharmaTher Holdings Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.01 0.00 0.00 0.00

PharmaTher Holdings EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

PharmaTher Holdings's Basic EPS for the fiscal year that ended in May. 2025 is calculated as

Basic EPS (A: May. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.1-0)/88.519
=-0.01

PharmaTher Holdings's Basic EPS for the quarter that ended in Feb. 2026 is calculated as

Basic EPS (Q: Feb. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.001-0)/91.019
=-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-0.01 mean?
PharmaTher Holdings (PHRRF) has a EPS (Basic) of $-0.01 as of Feb. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on PharmaTher Holdings and its competitors.
Is PharmaTher Holdings' EPS (Basic) too high?
PharmaTher Holdings' current EPS (Basic) is $-0.01.
How does PharmaTher Holdings' EPS (Basic) compare to VRTX and REGN?
PharmaTher Holdings' EPS (Basic) of $-0.01 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on PharmaTher Holdings and its competitors. PharmaTher Holdings's current EPS (Basic) is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaTher Holdings stock overvalued right now?
PharmaTher Holdings (PHRRF) has a current EPS (Basic) of $-0.01. The current EPS (Basic) is $-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For PharmaTher Holdings (PHRRF), the current EPS (Basic) is $-0.01 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaTher Holdings Business Description

Other Exchanges NCC0:GermanyPHRM:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch and others.